Aichi (1)

Miyagi (1)

Tokyo (1)

Chronic Lymphocytic Leukemia (1)

Follicular Lymphoma (1)

Indolent Non-Hodgkin Lymphoma (1)

Lymphoplasmacytic Lymphoma (With or Without Waldenstrom Macroglobulinemia) (1)

Marginal Zone Lymphoma (1)

Small Lymphocytic Lymphoma (1)

Completed (1)

phase 1 (1)

Gilead Sciences (1)

idelalisib (1)

drug (1)

Industry (1)

Interventional (1)

lymphoplasmacytic lymphoma (with or without waldenstrom macroglobulinemia)

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Completed

Feb 24, 2021